Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
AUS.: +61-2-4786-0457
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Life Sciences BPO market 2020 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2026

  • Purchase Options

 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Report Description
Life science business process outsourcing (BPO) is one of the most lucrative industries in the healthcare sector. Constantly rising pricing pressure and increasing competition is compelling pharmaceutical and medical device companies to strategically reduce their operational costs and in turn benefit from higher profits. This has led to an increasing demand for contract manufacturing outsourcing (CMO) and contract research outsourcing (CRO) services. Asia and Latin America are the most attractive markets for CMO and CRO, owing to low costs of production and research activities performed here.
Market Dynamics
The global life sciences BPO market is driven by factors such as increasing cost of research and development (R&D), growing price pressures, and increase in investments by pharmaceutical and medical devices companies in emerging economies such as India, China, Brazil, and South Africa. Pharmaceutical and medical device companies are adopting inorganic growth strategies to expand their business and reduce their Capital Expenditure (CAPEX) and Operation Costs (OPEX). However, outsourcing certain services to different CMO and CRO companies located in other countries is a challenge for the outsourcing company to monitor and follow a particular set of guideline for product approval pertaining to regulatory filings, clinical trials and medical writing. Collaborative efforts among various stakeholders of the ecosystem is analyzed to benefit the life science BPO industry in the long run.
Market Taxonomy
This report segments the life sciences BPO market on the basis of service type and end user. On the basis of service type, the global life sciences BPO market is analyzed for medical device outsourcing, pharmaceuticals outsourcing and regulatory information. The end users covered in the report are healthcare providers and healthcare payers.
 
Key features of the study:
• This report provides in-depth analysis of the life sciences BPO industry and provides market size (US$ Billion) and Cumulative Annual Growth Rate (CAGR) (%) for the forecast period (2016 - 2024), considering 2015 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides vital insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global life sciences BPO market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
• Key companies covered as a part of this study include Anthelio Healthcare Solutions, Accenture plc, Cognizant Technology Solutions, Catalent, Inc., Covance, Inc., Boehringer Ingelheim GmbH, Genpact Limited, Lonza Group, PAREXEL International Corporation and Quintiles Transnational Corporation.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision with respect to manufacturing or research outsourcing, cost reduction opportunities, and operational strategies
• The global life sciences BPO market report caters to various stakeholders in this industry including investors, pharmaceutical and medical device companies, contract manufacturers, contract research organizations, medical writing companies, pharmacovigilance companies, new entrants, and financial analysts
• Stakeholders would greatly benefit from various strategy matrices used in analyzing the life sciences BPO market, which would aid in effective decision making

Detailed Segmentation:
• Global Life Sciences BPO Market, By Service Type:
o Medical Device Outsourcing
o Pharmaceutical Outsourcing
 CMO
• API Manufacturing
• Final dosage form manufacturing
• Packaging
 CRO
• Drug Discovery
• Preclinical studies
• Early Phase I - IIa
• Phase IIa - III
• Phase IIIb - IV
• Medical coding and writing
• Monitoring
• Clinical Data Management
• Bio-statistics
• Site management
• Protocol development
o Regulatory Information
• Global Life Sciences BPO Market, By End User:
o Healthcare Providers
o Healthcare Payers
• Global Life Sciences BPO Market, By Geography:
o North America
 U.S.
• By Service Type:
o Medical Device Outsourcing
o Pharmaceutical Outsourcing
 CMO
• API Manufacturing
• Final dosage form manufacturing
• Packaging
 CRO
• Drug Discovery
• Preclinical studies
• Early Phase I - IIa
• Phase IIa - III
• Phase IIIb - IV
• Medical coding and writing
• Monitoring
• Clinical Data Management
• Bio-statistics
• Site management
• Protocol development
o Regulatory Information
• By End User:
o Healthcare Providers
o Healthcare Payers
 Canada
• By Service Type:
o Medical Device Outsourcing
o Pharmaceutical Outsourcing
 CMO
• API Manufacturing
• Final dosage form manufacturing
• Packaging
 CRO
• Drug Discovery
• Preclinical studies
• Early Phase I - IIa
• Phase IIa - III
• Phase IIIb - IV
• Medical coding and writing
• Monitoring
• Clinical Data Management
• Bio-statistics
• Site management
• Protocol development
o Regulatory Information
• By End User:
o Healthcare Providers
o Healthcare Payers
o Europe
 UK
• By Service Type:
o Medical Device Outsourcing
o Pharmaceutical Outsourcing
 CMO
• API Manufacturing
• Final dosage form manufacturing
• Packaging
 CRO
• Drug Discovery
• Preclinical studies
• Early Phase I - IIa
• Phase IIa - III
• Phase IIIb - IV
• Medical coding and writing
• Monitoring
• Clinical Data Management
• Bio-statistics
• Site management
• Protocol development
o Regulatory Information
• By End User:
o Healthcare Providers
o Healthcare Payers
 Germany
• By Service Type:
o Medical Device Outsourcing
o Pharmaceutical Outsourcing
 CMO
• API Manufacturing
• Final dosage form manufacturing
• Packaging
 CRO
• Drug Discovery
• Preclinical studies
• Early Phase I - IIa
• Phase IIa - III
• Phase IIIb - IV
• Medical coding and writing
• Monitoring
• Clinical Data Management
• Bio-statistics
• Site management
• Protocol development
o Regulatory Information
• By End User:
o Healthcare Providers
o Healthcare Payers
 Italy
• By Service Type:
o Medical Device Outsourcing
o Pharmaceutical Outsourcing
 CMO
• API Manufacturing
• Final dosage form manufacturing
• Packaging
 CRO
• Drug Discovery
• Preclinical studies
• Early Phase I - IIa
• Phase IIa - III
• Phase IIIb - IV
• Medical coding and writing
• Monitoring
• Clinical Data Management
• Bio-statistics
• Site management
• Protocol development
o Regulatory Information
• By End User:
o Healthcare Providers
o Healthcare Payers
 France
• By Service Type:
o Medical Device Outsourcing
o Pharmaceutical Outsourcing
 CMO
• API Manufacturing
• Final dosage form manufacturing
• Packaging
 CRO
• Drug Discovery
• Preclinical studies
• Early Phase I - IIa
• Phase IIa - III
• Phase IIIb - IV
• Medical coding and writing
• Monitoring
• Clinical Data Management
• Bio-statistics
• Site management
• Protocol development
o Regulatory Information
• By End User:
o Healthcare Providers
o Healthcare Payers
 Russia
• By Service Type:
o Medical Device Outsourcing
o Pharmaceutical Outsourcing
 CMO
• API Manufacturing
• Final dosage form manufacturing
• Packaging
 CRO
• Drug Discovery
• Preclinical studies
• Early Phase I - IIa
• Phase IIa - III
• Phase IIIb - IV
• Medical coding and writing
• Monitoring
• Clinical Data Management
• Bio-statistics
• Site management
• Protocol development
o Regulatory Information
• By End User:
o Healthcare Providers
o Healthcare Payers
 Rest of Europe
• By Service Type:
o Medical Device Outsourcing
o Pharmaceutical Outsourcing
 CMO
• API Manufacturing
• Final dosage form manufacturing
• Packaging
 CRO
• Drug Discovery
• Preclinical studies
• Early Phase I - IIa
• Phase IIa - III
• Phase IIIb - IV
• Medical coding and writing
• Monitoring
• Clinical Data Management
• Bio-statistics
• Site management
• Protocol development
o Regulatory Information
• By End User:
o Healthcare Providers
o Healthcare Payers
o Asia-Pacific
 China
• By Service Type:
o Medical Device Outsourcing
o Pharmaceutical Outsourcing
 CMO
• API Manufacturing
• Final dosage form manufacturing
• Packaging
 CRO
• Drug Discovery
• Preclinical studies
• Early Phase I - IIa
• Phase IIa - III
• Phase IIIb - IV
• Medical coding and writing
• Monitoring
• Clinical Data Management
• Bio-statistics
• Site management
• Protocol development
o Regulatory Information
• By End User:
o Healthcare Providers
o Healthcare Payers
 India
• By Service Type:
o Medical Device Outsourcing
o Pharmaceutical Outsourcing
 CMO
• API Manufacturing
• Final dosage form manufacturing
• Packaging
 CRO
• Drug Discovery
• Preclinical studies
• Early Phase I - IIa
• Phase IIa - III
• Phase IIIb - IV
• Medical coding and writing
• Monitoring
• Clinical Data Management
• Bio-statistics
• Site management
• Protocol development
o Regulatory Information
• By End User:
o Healthcare Providers
o Healthcare Payers
 Japan
• By Service Type:
o Medical Device Outsourcing
o Pharmaceutical Outsourcing
 CMO
• API Manufacturing
• Final dosage form manufacturing
• Packaging
 CRO
• Drug Discovery
• Preclinical studies
• Early Phase I - IIa
• Phase IIa - III
• Phase IIIb - IV
• Medical coding and writing
• Monitoring
• Clinical Data Management
• Bio-statistics
• Site management
• Protocol development
o Regulatory Information
• By End User:
o Healthcare Providers
o Healthcare Payers
 ASEAN
• By Service Type:
o Medical Device Outsourcing
o Pharmaceutical Outsourcing
 CMO
• API Manufacturing
• Final dosage form manufacturing
• Packaging
 CRO
• Drug Discovery
• Preclinical studies
• Early Phase I - IIa
• Phase IIa - III
• Phase IIIb - IV
• Medical coding and writing
• Monitoring
• Clinical Data Management
• Bio-statistics
• Site management
• Protocol development
o Regulatory Information
• By End User:
o Healthcare Providers
o Healthcare Payers
 Australia
• By Service Type:
o Medical Device Outsourcing
o Pharmaceutical Outsourcing
 CMO
• API Manufacturing
• Final dosage form manufacturing
• Packaging
 CRO
• Drug Discovery
• Preclinical studies
• Early Phase I - IIa
• Phase IIa - III
• Phase IIIb - IV
• Medical coding and writing
• Monitoring
• Clinical Data Management
• Bio-statistics
• Site management
• Protocol development
o Regulatory Information
• By End User:
o Healthcare Providers
o Healthcare Payers
 South Korea
• By Service Type:
o Medical Device Outsourcing
o Pharmaceutical Outsourcing
 CMO
• API Manufacturing
• Final dosage form manufacturing
• Packaging
 CRO
• Drug Discovery
• Preclinical studies
• Early Phase I - IIa
• Phase IIa - III
• Phase IIIb - IV
• Medical coding and writing
• Monitoring
• Clinical Data Management
• Bio-statistics
• Site management
• Protocol development
o Regulatory Information
• By End User:
o Healthcare Providers
o Healthcare Payers
 Rest of Asia Pacific
• By Service Type:
o Medical Device Outsourcing
o Pharmaceutical Outsourcing
 CMO
• API Manufacturing
• Final dosage form manufacturing
• Packaging
 CRO
• Drug Discovery
• Preclinical studies
• Early Phase I - IIa
• Phase IIa - III
• Phase IIIb - IV
• Medical coding and writing
• Monitoring
• Clinical Data Management
• Bio-statistics
• Site management
• Protocol development
o Regulatory Information
• By End User:
o Healthcare Providers
o Healthcare Payers
o Latin America
 Brazil
• By Service Type:
o Medical Device Outsourcing
o Pharmaceutical Outsourcing
 CMO
• API Manufacturing
• Final dosage form manufacturing
• Packaging
 CRO
• Drug Discovery
• Preclinical studies
• Early Phase I - IIa
• Phase IIa - III
• Phase IIIb - IV
• Medical coding and writing
• Monitoring
• Clinical Data Management
• Bio-statistics
• Site management
• Protocol development
o Regulatory Information
• By End User:
o Healthcare Providers
o Healthcare Payers
 Mexico
• By Service Type:
o Medical Device Outsourcing
o Pharmaceutical Outsourcing
 CMO
• API Manufacturing
• Final dosage form manufacturing
• Packaging
 CRO
• Drug Discovery
• Preclinical studies
• Early Phase I - IIa
• Phase IIa - III
• Phase IIIb - IV
• Medical coding and writing
• Monitoring
• Clinical Data Management
• Bio-statistics
• Site management
• Protocol development
o Regulatory Information
• By End User:
o Healthcare Providers
o Healthcare Payers
 Rest of Latin America
• By Service Type:
o Medical Device Outsourcing
o Pharmaceutical Outsourcing
 CMO
• API Manufacturing
• Final dosage form manufacturing
• Packaging
 CRO
• Drug Discovery
• Preclinical studies
• Early Phase I - IIa
• Phase IIa - III
• Phase IIIb - IV
• Medical coding and writing
• Monitoring
• Clinical Data Management
• Bio-statistics
• Site management
• Protocol development
o Regulatory Information
• By End User:
o Healthcare Providers
o Healthcare Payers
o Middle East
 GCC
• By Service Type:
o Medical Device Outsourcing
o Pharmaceutical Outsourcing
 CMO
• API Manufacturing
• Final dosage form manufacturing
• Packaging
 CRO
• Drug Discovery
• Preclinical studies
• Early Phase I - IIa
• Phase IIa - III
• Phase IIIb - IV
• Medical coding and writing
• Monitoring
• Clinical Data Management
• Bio-statistics
• Site management
• Protocol development
o Regulatory Information
• By End User:
o Healthcare Providers
o Healthcare Payers
 Israel
• By Service Type:
o Medical Device Outsourcing
o Pharmaceutical Outsourcing
 CMO
• API Manufacturing
• Final dosage form manufacturing
• Packaging
 CRO
• Drug Discovery
• Preclinical studies
• Early Phase I - IIa
• Phase IIa - III
• Phase IIIb - IV
• Medical coding and writing
• Monitoring
• Clinical Data Management
• Bio-statistics
• Site management
• Protocol development
o Regulatory Information
• By End User:
o Healthcare Providers
o Healthcare Payers
o Africa
 North Africa
• By Service Type:
o Medical Device Outsourcing
o Pharmaceutical Outsourcing
 CMO
• API Manufacturing
• Final dosage form manufacturing
• Packaging
 CRO
• Drug Discovery
• Preclinical studies
• Early Phase I - IIa
• Phase IIa - III
• Phase IIIb - IV
• Medical coding and writing
• Monitoring
• Clinical Data Management
• Bio-statistics
• Site management
• Protocol development
o Regulatory Information
• By End User:
o Healthcare Providers
o Healthcare Payers
 Central Africa
• By Service Type:
o Medical Device Outsourcing
o Pharmaceutical Outsourcing
 CMO
• API Manufacturing
• Final dosage form manufacturing
• Packaging
 CRO
• Drug Discovery
• Preclinical studies
• Early Phase I - IIa
• Phase IIa - III
• Phase IIIb - IV
• Medical coding and writing
• Monitoring
• Clinical Data Management
• Bio-statistics
• Site management
• Protocol development
o Regulatory Information
• By End User:
o Healthcare Providers
o Healthcare Payers
 South Africa
• By Service Type:
o Medical Device Outsourcing
o Pharmaceutical Outsourcing
 CMO
• API Manufacturing
• Final dosage form manufacturing
• Packaging
 CRO
• Drug Discovery
• Preclinical studies
• Early Phase I - IIa
• Phase IIa - III
• Phase IIIb - IV
• Medical coding and writing
• Monitoring
• Clinical Data Management
• Bio-statistics
• Site management
• Protocol development
o Regulatory Information
• By End User:
o Healthcare Providers
o Healthcare Payers
• Company Profiles
o Anthelio Healthcare Solutions*
 Company Overview
 Product Portfolio
 Financial Performance
 Key Strategies
 Recent Developments
 Future Plans
o Accenture plc
o Cognizant Technology Solutions
o Catalent, Inc.
o Covance, Inc.
o Boehringer Ingelheim GmbH
o Genpact Limited
o Lonza Group
o PAREXEL International Corporation
o Quintiles Transnational Corporation

"*" marked represents similar segmentation in other categories in the respective section.


Table of Contents
1. Research Objective and assumption
• Research Objectives
• Assumptions
• Abbreviations
2. Market Purview
• Report Description
o Market Definition and Scope
• Executive Summary
o Market Snippet By Service
o Market Snippet By End-User
• Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
• Market Dynamics
o Drivers
? Supply Side Drivers
? Demand Side Drivers
? Economic Drivers
o Restraints
o Market Opportunities
o Industry Trend
o Merger and Acquisitions
• Cost Tier Down Analysis
4. Global Life Science BPO Market, By Service, 2014 - 2024 (USD Million)
• Introduction
o Market Share Analysis, 2015 and 2024 (%)
o Y-O-Y Growth Analysis, 2014 - 2024
o Segment Trends
• Pharmaceutical Outsourcing
o Introduction
? Market Share Analysis, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, 2014 - 2024
? Segment Trends
o CMO
? Introduction
o Market Share Analysis, 2015 and 2024 (%)
o Y-O-Y Growth Analysis, 2014 - 2024
? API Manufacturing
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million)
? Dosage Form Manufacturing
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million)
? Product Packaging
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million)
o CRO
? Introduction
o Market Share Analysis, 2015 and 2024 (%)
o Y-O-Y Growth Analysis, 2014 - 2024
? Drug Discovery
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million)
? Preclinical Studies
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million)
? Phase I Studies
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million)
? Phase II Studies
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million)
? Phase III and IV Studies
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million)
? Medical Coding and Writing
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million)
? Patient Monitoring
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million)
? Clinical Data Management
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million)
? Site Management
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million)
? Bio-Statistics
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million)
? Protocol Development
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million)
• Medical Device Outsourcing
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million)
• Regulatory Information
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million)
5. Global Life Science BPO Market, By End-User, 2014 - 2024 (USD Million)
• Introduction
o Market Share Analysis, 2015 and 2024 (%)
o Y-O-Y Growth Analysis, 2014 - 2024
o Segment Trends
• Healthcare Providers
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million)
• Healthcare Payers
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million)
6. Global Life Science BPO Market, By Regions, 2014 - 2024 (USD Million)
• Introduction
o Market Share Analysis, By Region, 2015 and 2024 (%)
o Y-O-Y Growth Analysis, For Regions, 2014 - 2024
• North America
o Market Share Analysis, By Country, 2015 and 2024 (%)
o Y-O-Y Growth Analysis, By Country, 2014 - 2024
? U.S.
? Country Trends
? Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
? Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
? Canada
? Country Trends
? Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
? Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
• Europe
o Market Share Analysis, By Country, 2015 and 2024 (%)
o Y-O-Y Growth Analysis, By Country, 2014 - 2024
? U.K.
? Country Trends
? Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
? Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
? Germany
? Country Trends
? Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
? Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
? Italy
? Country Trends
? Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
? Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
? France
? Country Trends
? Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
? Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
? Russia
? Country Trends
? Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
? Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
? Others
? Country Trends
? Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
? Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
• Asia Pacific
o Market Share Analysis, By Country, 2015 and 2024 (%)
o Y-O-Y Growth Analysis, By Country, 2014 - 2024
? China
? Country Trends
? Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
? Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
? India
? Country Trends
? Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
? Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
? Japan
? Country Trends
? Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
? Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
? ASEAN
? Country Trends
? Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
? Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
? Australia
? Country Trends
? Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
? Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
? South Korea
? Country Trends
? Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
? Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
? Others
? Country Trends
? Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
? Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
• Latin America
o Market Share Analysis, By Country, 2015 and 2024 (%)
o Y-O-Y Growth Analysis, By Country, 2014 - 2024
? Brazil
? Country Trends
? Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
? Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
? Mexico
? Country Trends
? Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
? Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
? Others
? Country Trends
? Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
? Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
• Africa
o Market Share Analysis, By Country, 2015 and 2024 (%)
o Y-O-Y Growth Analysis, By Country, 2014 - 2024
? Northern Africa
? Country Trends
? Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
? Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
? Central Africa
? Country Trends
? Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
? Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
? South Africa
? Country Trends
? Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
? Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
• Middle East
o Market Share Analysis, By Country, 2015 and 2024 (%)
o Y-O-Y Growth Analysis, By Country, 2014 - 2024
? GCC Countries
? Country Trends
? Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
? Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
? Israel
? Country Trends
? Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
? Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
7. Competitive Landscape
• Heat Map Analysis
• Market Share Analysis
• Company Profiles
o Accenture plc.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
o Anthelio Healthcare Solutions
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
o Boehringer Ingelheim GmbH
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
o Catalent, Inc.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
o Covance, Inc.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
o Genpact Ltd.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
o ICON plc
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
o Infosys Limited
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
o International Business Machines Corporation
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
o Lonza Group
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
o PAREXEL International Corporation
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
o Quintiles Transnational Corporation
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
• Analyst Views
8. Section
• References
• Research Methodology
• About us and Sales Contact
 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us